ScreenPro Security Inc. (CSE: SCRN) (OTSCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to provide an update on productions serviced by ScreenPro and the GoStop app (the "App") presently deployed with its film and television clients.

The Company is currently working with over 30 film and television productions in British Columbia, Ontario and Quebec as well as providing concierge services to productions within those regions. The GoStop App is an integral part of the reporting software for the productions, providing pushed COVID-19 screening results to cast and crew members, as well as automated identification codes for our laboratories and analytics to productions and on their testing cadence.

Lena Kozovski, CEO of ScreenPro Security commented, "GoStop is an essential reporting platform for ScreenPro clientele, assisting with individual results for screening purposes, as well as assisting with our COVID screening analytics and it is also integrated with our laboratory patient identification system. Productions employ hundreds of office employees, film technicians, and actors per production over multiple locations, including offices, carpenter shops, studios and on location. It is critical to communicate to all stakeholders any positive results that might shut down a multi million-dollar production."

About ScreenPro

ScreenPro is a Screening and Medical Technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario, and Quebec allowing ScreenPro to be a full-service nationwide provider of COVID testing solutions across Canada. In addition, ScreenPro has its own medical doctor and nursing professionals along with on the ground support staff and transportation, as access to high quality PPEs to ensure that its clients are protected in all aspects of their testing needs. ScreenPro provides alerting software through its secure GoStop application that enables individuals to use the app for test screening results as well as provides automated identification codes for our laboratories and analytics to our clients on their testing cadence. For additional information on ScreenPro and other corporate information, please visit the Company's website at

For more information about the Company, please refer to the Company's profile on SEDAR at

Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For further information please contact:

Jamie Hyland, Director
P. (604) 442-2425

Forward Looking Statements:

Certain statements contained in this news release may constitute forward‐looking information, including statements relating to expectations regarding acquisition of Concierge Medical Consultants Inc. and the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.


To view the source version of this press release, please visit

News Provided by Newsfile via QuoteMedia

Forward Water Technologies Announces Second Quarter 2022 Financial Results

Forward Water Technologies Announces Second Quarter 2022 Financial Results

Forward Water Technologies Corp. (TSXV:FWTC) (the "Company" or "FWTC") is pleased to announce that it has filed its condensed consolidated un-audited financial statements and related management's discussion and analysis for the three and six months ended September 31, 2022 and 2021. Copies of these financial statements and related management's discussion and analysis can be found on the Company's issuer profile at All financial information in this news release is reported in Canadian dollars, unless otherwise indicated

Q2 Financial Highlights

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
ScreenPro Reports Positive Cash Flow in Q3

ScreenPro Reports Positive Cash Flow in Q3

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") announces its financial results for the third quarter. The Company has filed its financial statements ("FS") and related management discussion and analysis ("MD&A") on SEDAR for the quarterly results ending September 30, 2022 ("Q3 2022").

Q3 2022 Financial Summary

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Lake Resources NL  Provides Kachi Project Contract Update

Lake Resources NL Provides Kachi Project Contract Update

Sydney, Australia (ABN Newswire) - Clean lithium developer Lake Resources NL (ASX:LKE) (FRA:LK1) (OTCMKTS:LLKKF) is pleased to advise that a contract amendment has been signed to resolve the dispute between Lilac Solutions ("Lilac") and Lake Resources ("Lake"). This amendment allows the teams to reset the relationship and jointly focus on delivery of the world class Kachi Project which will lead the industry in terms of high-quality Lithium produced with a minimal environmental footprint. In resolving the dispute, Lake and Lilac have agreed to an amended timeline which both are confident can be achieved; as before, Lake will have certain buy back rights if Lilac does not meet agreed testing criteria in a timely manner.

Lilac and Lake continue work at the Kachi Project Demonstration Plant, with performance of the plant in line with expectations. The Demonstration Plant has now produced more than 15% of the total Demonstration Plant forecast output in the short period since the Plant came online this quarter. 20,000 litres of LiCl have been produced to date and ongoing production is proceeding, consistent with the Demonstration Plant's planned operational schedule.

The Demonstration Plant is currently operating continuously at 90 percent of steady state capacity, volume, and production. Hatch Ltd engineering personnel will travel to Argentina to observe and validate the operations of demonstration plant in steady state in coming weeks.

The Kachi Demonstration Plant continues to produce in-spec LiCl solution between 1900 and 3800 mg/L.

Previous testing on Kachi brines at Lilac's California headquarters Oakland delivered 1400-2354mg/L.

Lilac Solutions is preparing samples for shipment to Saltworks and Lilac's facility in Oakland CA for conversion into Lithium Carbonate.

Lake CEO and MD David Dickson said the progress and test work being achieved was promising.

"We are fortunate to be working with Lilac as our partner, who is equally interested in doing things differently so we can efficiently deliver the large volumes of high-quality lithium chemicals needed by battery makers.

"Importantly, this lithium can be produced cleanly and in a way that respects and involves local communities and protects the environment.

"Lilac has worked extensively with Kachi brine since 2020, generating the data needed for engineering studies. These next steps, along with the strong alignment of our companies, are quite encouraging," he said.

Lilac Solutions CEO David Snydacker commented, "Lilac and Lake are working together closely to set a new standard for pace of project development in the lithium industry. Progressing the on-site plant from completion of construction to shipping of on-spec bulk samples of lithium chloride in just two months is significantly faster than conventional projects move, where commissioning of evaporation ponds typically takes many years. We expect to continue to improve upon the traditional project development timeline as we advance toward commercial production, ultimately bringing the Kachi project on-line years ahead of competing projects. This will put the Kachi project in an excellent position to supply the lithium raw material urgently needed by automakers and capture the high prices we see in the market due to the failure of conventional approaches."

About Lake Resources NL:

Lake Resources NL (ASX:LKE) (OTCMKTS:LLKKF) is a clean lithium developer utilising clean, direct extraction technology for the development of sustainable, high purity lithium from its flagship Kachi Project, as well as three other lithium brine projects in Argentina. The projects are in a prime location within the Lithium Triangle, where 40% of the world's lithium is produced at the lowest cost.

This method will enable Lake Resources to be an efficient, responsibly-sourced, environmentally friendly and cost competitive supplier of high-purity lithium, which is readily scalable, and in demand from Tier 1 electric vehicle makers and battery makers.

News Provided by ABN Newswire via QuoteMedia

Keep reading...Show less
Premier Health Announces TSXV Approval of Normal Course Issuer Bid

Premier Health Announces TSXV Approval of Normal Course Issuer Bid

Premier Health of America Inc. (TSXV: PHA) (the " Corporation " or " Premier Health "), a leading Canadian Healthtech company, announced today that the TSX Venture Exchange (" TSXV ") has accepted the Corporation's application for its normal course issuer bid (the " NCIB ") for a portion of its outstanding common shares (" Common Shares ") as appropriate opportunities arise from time to time. The Corporation's NCIB will be made in accordance with the requirements of the TSXV and applicable securities laws.

Pursuant to the NCIB, Premier Health may repurchase up to a maximum of 1,428,571 Common Shares representing approximately a value of $500,000 at the current market price and 7% of its public float, where the aggregate public float as at November 14, 2022, was 19,664,860 Common Shares. Purchases under the NCIB may be made through the facilities of the TSXV, based on the prevailing market price at the time of acquisition. The NCIB will be funded using existing cash resources and any Common Shares purchased under the NCIB will be cancelled.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Montfort Capital Announces Special Meeting

Montfort Capital Announces Special Meeting

~Montfort proposes two new classes of preferred shares to strengthen capital structure~

Montfort Capital Corporation (" Montfort " or the " Company ") (TSXV: MONT) (OTCQB: MONTF), a leading innovator of technology in private credit, is pleased to announce that a special meeting of its shareholders (the "Meeting") will be held December 9, 2022 at 9:00am ( Vancouver time) to seek shareholder approvals necessary to modify the capital share structure of the Company.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
ScreenPro Announces Non-Brokered Private Placement Financing

ScreenPro Announces Non-Brokered Private Placement Financing

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce a non-brokered private placement financing of up to 20 million units of the Company ("Units") at a price of $0.05 per Unit (the "Private Placement").

Each Unit will consist of one (1) common share of the Company ("Share") and one (1) common share purchase warrant ("Warrant"). Each warrant will entitle the holder thereof to acquire one Share of the Company at a price of $0.05 per Share for a period of eighteen (18) months from the date of issuance.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News